Glaucoma: New Diagnostic and Therapeutic Approaches, 2nd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 45
Special Issue Editor
Interests: glaucoma; ocular pharmacology; cataract
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are delighted to present a Special Issue, entitled "Glaucoma: New Diagnostic and Therapeutic Approaches, 2nd Edition ," focusing on the latest advancements in the field of glaucoma management. Glaucoma remains one of the leading causes of irreversible blindness worldwide, necessitating the continuous exploration of novel approaches to improve patient outcomes. This Special Issue aims to provide a comprehensive overview of cutting-edge research and innovations in glaucoma management, highlighting emerging techniques and interventions that hold promise in the diagnosis, monitoring, and treatment of this complex ocular disease.
This Special Issue seeks to foster collaboration among researchers, clinicians, and industry professionals, facilitating the dissemination of knowledge and the exchange of ideas in the field of glaucoma. We invite original research articles, comprehensive reviews, and perspectives that cover a broad range of topics, including, but not limited to, the following:
- Novel diagnostic techniques—articles elucidating the development and clinical application of innovative imaging modalities, genetic testing, and biomarkers for early detection and accurate diagnosis;
- Advanced therapeutic interventions—pharmacological advancements and emerging therapies for glaucoma management, with an emphasis on their efficacy, safety, and long-term outcomes;
- Artificial intelligence and digital health—research exploring the integration of artificial intelligence, machine learning, and digital health technologies in glaucoma screening, monitoring, and personalized treatment approaches.
Dr. Da-Wen Lu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glaucoma
- ocular pharmacology
- ocular disease
